Gough M - Search Results

1

Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.

Crittenden M, Gough M, Chester J, Kottke T, Thompson J, Ruchatz A, Clackson T, Cosset FL, Chong H, Diaz RM, Harrington K, Alvarez Vallina L, Vile R. Crittenden M, et al. Among authors: gough m. Cancer Res. 2003 Jun 15;63(12):3173-80. Cancer Res. 2003. PMID: 12810645

2

Different approaches in the gene therapy of cancer.

Gough MJ, Vile RG. Gough MJ, et al. Forum (Genova). 1999 Jul-Sep;9(3):225-36. Forum (Genova). 1999. PMID: 10504170 Review.

3

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

Melcher A, Gough M, Todryk S, Vile R. Melcher A, et al. Among authors: gough m. J Mol Med (Berl). 1999 Dec;77(12):824-33. doi: 10.1007/s001099900066. J Mol Med (Berl). 1999. PMID: 10682318 Review.

4

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.

Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R. Emiliusen L, et al. Among authors: gough m. Gene Ther. 2001 Jul;8(13):987-98. doi: 10.1038/sj.gt.3301470. Gene Ther. 2001. PMID: 11438833

5

Macrophages orchestrate the immune response to tumor cell death.

Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, Vile RG. Gough MJ, et al. Cancer Res. 2001 Oct 1;61(19):7240-7. Cancer Res. 2001. PMID: 11585761

6

Cell death associated with genetic prodrug activation therapy of colorectal cancer.

Todryk S, Melcher A, Bottley G, Gough M, Vile R. Todryk S, et al. Among authors: gough m. Cancer Lett. 2001 Dec 10;174(1):25-33. doi: 10.1016/s0304-3835(01)00679-6. Cancer Lett. 2001. PMID: 11675149

7

Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.

Chester J, Ruchatz A, Gough M, Crittenden M, Chong H, Cosset FL, Diaz RM, Harrington K, Alvarez-Vallina L, Vile R. Chester J, et al. Among authors: gough m. Nat Biotechnol. 2002 Mar;20(3):256-63. doi: 10.1038/nbt0302-256. Nat Biotechnol. 2002. PMID: 11875426

8

Dendritic cells for the immunotherapy of cancer.

Melcher A, Bateman A, Harrington K, Ahmed A, Gough M, Vile R. Melcher A, et al. Among authors: gough m. Clin Oncol (R Coll Radiol). 2002 Jun;14(3):185-92. doi: 10.1053/clon.2001.0038. Clin Oncol (R Coll Radiol). 2002. PMID: 12109820 Review. No abstract available.

9

Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?

Harrington K, Alvarez-Vallina L, Crittenden M, Gough M, Chong H, Diaz RM, Vassaux G, Lemoine N, Vile R. Harrington K, et al. Among authors: gough m. Hum Gene Ther. 2002 Jul 20;13(11):1263-80. doi: 10.1089/104303402760128504. Hum Gene Ther. 2002. PMID: 12162810 Review.

10

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Among authors: gough m. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters